# Peter Farrell

> Peter Farrell is a pre-seed investor at ResMed (San Diego) backing Software and FinTech. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ResMed](https://shizune.co/investors/profile/resmed)
- Location: San Diego, United States
- Total investments: 4
- Last investment: Jun 2023
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/peter-farrell-8989ab6
- Website: https://x.com/fa331250901

Peter Farrell is a pre-seed investor at ResMed in San Diego focused on Software and FinTech. Peter C. Farrell is based out of San Diego, California and is the Founder and Chair Emeritus of ResMed. Peter previously worked at Baxter International, Inc as a vice president of research and development. Peter C. Farrell attended the Massachusetts Institute of Technology.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 2 | 50% |
| FinTech | 1 | 25% |
| Payments | 1 | 25% |
| Aerospace | 1 | 25% |
| Health Care | 1 | 25% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 1 | 25% |
| Series A | 1 | 25% |
| Funding Round | 1 | 25% |
| Convertible Note | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Up 'n go - Pay at table | Upngo enables contactless payments at over 1,000 restaurants across almost every state in the US. Since launching in 2018, the company has processed millions of contactless payments for restaurant guests. Over 3.5 million payments totaling over $250 million annually are processed by QR code or text payments. | $600K | Pre-Seed | Jun 01, 2023 |  |
| Mikroscan | Mikroscan is committed to partnering with the pathology community by providing technology-enabled products and services that increase a pathologist’s reach, remove barriers to workload efficiency, and enable new discoveries.Their solutions are utilized in hospitals, clinics, universities, and research institutions all over the world. From mobileMOHS labs to medical schools, their technology serves a variety of applications in anatomic pathology, veterinary pathology, teaching, and research settings. Deployed on a tablet, laptop, and desktop systems, Mikroscan’s local and cloud-based solutions address some of the most challenging issues associated with pathology today.Mikroscan was founded in 2011 and headquartered in Carlsbad, California. | $1.5M | Convertible Note | Aug 17, 2015 |  |
| Mikroscan | Mikroscan is committed to partnering with the pathology community by providing technology-enabled products and services that increase a pathologist’s reach, remove barriers to workload efficiency, and enable new discoveries.Their solutions are utilized in hospitals, clinics, universities, and research institutions all over the world. From mobileMOHS labs to medical schools, their technology serves a variety of applications in anatomic pathology, veterinary pathology, teaching, and research settings. Deployed on a tablet, laptop, and desktop systems, Mikroscan’s local and cloud-based solutions address some of the most challenging issues associated with pathology today.Mikroscan was founded in 2011 and headquartered in Carlsbad, California. | $4.7M | Series A | Aug 17, 2015 |  |
| Moon Express | Moon Express is a privately financed commercial space company blazing a trail to the Moon. Their prime directive is to open up the Moon’s vast resources for humanity and establish new avenues for commercial space activities beyond Earth orbit. They begin with profitable on-ramps by disrupting space transportation with innovative, flexible, andscalable new spacecraft that will radically reduce the cost of commercial robotic space activities. In doing so they will extend the economic sphere of Earth and make the resources of the Moon and asteroids accessible.They have a team of driven, visionary people merging the best practices of traditional aerospace know-how with the innovation and entrepreneurial culture of Silicon Valley. They have partnerships with NASA as both collaborators and customers. They have signed a contract with NASA for lunar cargo delivery, and NASA has selected Moon Express as a partner in developing lunar landers to put the U.S. back on the surface of the Moon.The company was founded by Dr. Bob Richards, Naveen Jain, and Dr. Barney Pell in August 2010 and was quickly selected by NASA for its $30M Innovative Lunar Demonstrations Data (ILDD) program. Moon Express entered and became the recognized leader in the $30M Google Lunar XPRIZE competition in October of that same year, and in 2014 was selected by NASA for its Lunar CATALYST program focused on a U.S. return to the Moon. Moon Express is headquartered at the NASA Ames Research Park in Mountain View, California, with facilities and operations in Huntsville, Alberta, and at the Kenneday Space Center and Cape Canaveral, Florida. | $12.5M |  | Dec 01, 2013 |  |

4 of 4 investments shown.

## Co-investors
- [Autodesk](https://shizune.co/investors/profile/autodesk) — VC Fund, 1 deal together
- [Innovative Fund](https://shizune.co/investors/profile/innovative-fund) — VC Fund, 1 deal together
- [Richmond Global Ventures](https://shizune.co/investors/profile/richmond-global) — VC Fund, 1 deal together

## About ResMed

VC Fund · San Diego, United States

At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platformssupport the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

5 contacts available at ResMed.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Huxter | VP Northern Europe & Growth Markets EMEA | https://shizune.co/investors/profile/andrew-huxter-f911 |
| Brett Sandercock | Chief Financial Officer | https://shizune.co/investors/profile/brett-sandercock |
| David Greatorex | Founding Investor | https://shizune.co/investors/profile/david-greatorex |
| Peter Farrell | Founder and Chair Emeritus | https://shizune.co/investors/profile/peter-farrell-2-2 |
| Aaron Bloomer | CFO, Principal Financial Officer and Principal Accounting Officer | https://shizune.co/investors/profile/aaron-bloomer |

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors](https://shizune.co/investors/medical-device-angel-investors)
- [Medical Device Angel Investors in United States](https://shizune.co/investors/medical-device-angel-investors-united-states)

## FAQ

### What does Peter Farrell invest in?

Peter Farrell invests primarily in Software, FinTech and Payments startups, most often at Pre-Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Peter Farrell last invest?

The most recent investment recorded for Peter Farrell closed in Jun 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co